SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-019476
Filing Date
2022-10-12
Accepted
2022-10-12 06:50:51
Documents
14
Period of Report
2022-10-11
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K grna-20221011.htm   iXBRL 8-K 68933
  Complete submission text file 0000950170-22-019476.txt   262581

Data Files

Seq Description Document Type Size
2 EX-99.PRESSRELEASE grna-ex99_pressrelease.htm EX-99.PRESSRELEASE 28194
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grna-20221011.xsd EX-101.SCH 3461
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grna-20221011_lab.xml EX-101.LAB 18086
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grna-20221011_def.xml EX-101.DEF 13862
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grna-20221011_pre.xml EX-101.PRE 13162
8 EXTRACTED XBRL INSTANCE DOCUMENT grna-20221011_htm.xml XML 6661
Mailing Address 200 BOSTON AVENUE SUITE 3100 MEDFORD MA 02155
Business Address 200 BOSTON AVENUE SUITE 3100 MEDFORD MA 02155 (617) 616-8188
GreenLight Biosciences Holdings, PBC (Filer) CIK: 0001822691 (see all company filings)

IRS No.: 851914700 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39894 | Film No.: 221305560
SIC: 2836 Biological Products, (No Diagnostic Substances)